FDA to Consider Neuronetics Device
MSN MoneyCentral - that could potentially compete with Cyberonics' Vagus Nerve stimulator, the only device on the market to treat major depression. device became the first to receive FDA approval to treat depressed patients who do not respond to drug treatment. Last
Source: news.moneycentral.msn.com
Social phobia/Social Anxiety Disorder
Health 24 - Other comorbid disorders commonly occurring with social phobia are agoraphobia, alcohol abuse, major depression and drug abuse. A factor complicating the successful treatment of Social Phobia is the fact that patients are very likely to receive
Source: www.health24.com
US Suicide Rates by Age Group, 1970-2002: An Examination of Recent
Medscape News - variables that may influence rates differentially. The relative contributions of depression diagnosis and treatment associated with a higher risk for suicide. [4,5] Other risk factors for suicide include previous diagnosis of major depression
Source: www.medscape.com
U.S. military is holding at least four Iranians in Iraq.
Slate - Its supporters must conclusively show, however, that it is distinct from similar conditions, like major depression. Advocates of Eli Lilly and Co. won FDA approval to market the antidepressant fluoxetine—better-known as Prozac—as a treatment for
Source: www.slate.com
Cyberonics to Update FDA on Device Data
MSN MoneyCentral - Additionally, the company could soon face competition from newer depression-treatment devices. Cyberonics will brief a to vote on approval of a device from privately held Neuronetics, which uses magnetic pulses to relieve major depression. The
Source: news.moneycentral.msn.com
Click here for more information about pregnancy depression pregnancy depression
